APA (7th ed.) Citation

Bid, H. K., Kibler, A., Phelps, D. A., Manap, S., Xiao, L., Lin, J., . . . Houghton, P. J. (2013). Development, characterization, and reversal of acquired resistance to the MEK1 inhibitor selumetinib (AZD6244) in an in vivo model of childhood astrocytoma. Clinical cancer research, 19(24), . https://doi.org/10.1158/1078-0432.CCR-13-0842

Chicago Style (17th ed.) Citation

Bid, Hemant Kumar, et al. "Development, Characterization, and Reversal of Acquired Resistance to the MEK1 Inhibitor Selumetinib (AZD6244) in an in Vivo Model of Childhood Astrocytoma." Clinical Cancer Research 19, no. 24 (2013). https://doi.org/10.1158/1078-0432.CCR-13-0842.

MLA (9th ed.) Citation

Bid, Hemant Kumar, et al. "Development, Characterization, and Reversal of Acquired Resistance to the MEK1 Inhibitor Selumetinib (AZD6244) in an in Vivo Model of Childhood Astrocytoma." Clinical Cancer Research, vol. 19, no. 24, 2013, https://doi.org/10.1158/1078-0432.CCR-13-0842.